(Total Views: 310)
Posted On: 06/14/2022 9:59:36 PM
Post# of 1418
Investors will get it. Company has 1000's of users of Tollovid to draw from which I assume many are in the standard-risk population category.
And this is Tollovid. Would Tollovir work even better in the standard-risk population? We shall see.
And this is Tollovid. Would Tollovir work even better in the standard-risk population? We shall see.
(1)
(0)
